Longitudinal benefit:risk analysis through the desirability of outcome ranking (DOOR) with application to ACTT-1 Trial.

Autor:	Shu, Shiyu1 (AUTHOR), Diao, Guoqing1 (AUTHOR) gdiao@email.gwu.edu, Hamasaki, Toshimitsu1 (AUTHOR), Evans, Scott1 (AUTHOR)
Zdroj:	Statistics in Biopharmaceutical Research. Oct2024, p1-17. 17p. 3 Illustrations.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu